Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer (Targeted Oncology, (2018), 10.1007/s11523-018-0587-9)

Sarah Sammons, Noah Kornblum, Kimberly L. Blackwell

Research output: Contribution to journalArticle

Abstract

The article Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer, written by Sarah Sammons, Noah S. Kornblum and Kimberly L. Blackwell, was originally published electronically on the publisher’s internet portal (currently SpringerLink).

Original languageEnglish (US)
JournalTargeted Oncology
DOIs
StateAccepted/In press - Jan 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Correction to: Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer (Targeted Oncology, (2018), 10.1007/s11523-018-0587-9)'. Together they form a unique fingerprint.

  • Cite this